SSJ Molecular Testing Qiagen VAPHCS_Redacted.pdf

This document is a Sole Source Justification for the Department of Veterans Affairs (VA) to procure Qiagen molecular testing reagents for the VA Pittsburgh Healthcare System. The procurement is for a Firm-Fixed Price 5-Year IDIQ contract with one-year ordering periods, specifically for molecular anatomic pathology testing kits including Therascreen EGFR RGQ PCR Kit, Therascreen KRAS RGQ PCR Kit, BRAF RGQ PCR Kit v2, and IDH ½ RGQ PCR Kit. These reagents are used for mutation detection in Non-Small Cell Lung Carcinomas, with specific quantities of 8 EGFR, 9 KRAS, 10 BRAF, and 2 IDH ½ RGQ PCR Kits. The contract's base year runs from 10/01/2025-09/30/2026, with four subsequent ordering periods through 09/03/2030. Market research was conducted, including GSA market research and RFI postings, which yielded zero responses, and Qiagen is identified as the only vendor with compatible EGFR RGQ PCR reagents for the Rotor-Gene Q MDx analyzers used at the VA facility.